Implanet Gains FDA Clearance for JAZZ Passer

By Julie A. Vetalice

IMPLANET received FDA 510(k) clearance to market JAZZ™ Passer, comprising spinal instruments and braided band technology that are compatible with all JAZZ platform implant connectors.

JAZZ Passer is a simplified system, designed in response to voice of surgeon customer, that facilitates placement of the JAZZ band around anatomical structures.

The company recently launched the JAZZ Braid device in the EU and U.S. as an improvement to the JAZZ spinal fusion platform.

Sources: IMPLANET; ORTHOWORLD Inc.

 

Product Labels: Spinal Fusion

Tags: 510(k) Clearance, Regulatory